Sean Sachdev

10PUBLICATIONS
106CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Psychological methodology, design and analysisMolecular targetsNanomedicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 26, 2026
Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205.

|Dec 15, 2025
Pediatric H3 K27-altered diffuse midline gliomas may consist of two clinically relevant subsets based on patient age and molecular genetic profile.

Yufan Yang, Nitin Wadhwani, Yuki Aoi

|Nov 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.

Deaglan McHugh, Matthew Dallos, Min Yuen Teo

|Apr 17, 2025
Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment.

Paul W Sperduto, Kathryn E Marqueen, Enoch Chang

|Feb 07, 2025
Clinical outcomes for pleomorphic xanthoastrocytoma patients.

Jared J Sullivan, James P Chandler, Maciej S Lesniak

|Jan 23, 2024
A valuable glioblastoma prognostic marker driven by radiosensitivity.

James Randall, Sean Sachdev

Pageof 2

Frequent Collaborators

2 joint publications

Roger Stupp

2 joint publications

Priya U Kumthekar

2 joint publications

Adam M Sonabend

1 joint publications

Derek A Wainwright